ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee Arthroplasty
NCT ID: NCT02574312
Last Updated: 2020-04-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2015-10-01
2019-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survivorship of Attune Primary Total Knee Prosthesis
NCT01754363
Alignment Comparison Between TruMatch™ Personalized Solutions and Conventional Total Knee Replacement Instrumentation
NCT01108237
Single-use Efficiency Instruments With Patient Specific Technique (MyKnee®) Versus Traditional Metal Instruments With Conventional Surgical Technique
NCT03148379
Comparison of Alignment Achieved Using the VELYS Robotic-Assisted Solution Versus Manual Instrumentation in Total Knee Arthroplasty
NCT04730271
Stereo Radiography of TKA Patella Mechanics
NCT02532933
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Up to four sites will recruit approximately 88 subjects. Each site is expected to implant the ATTUNE primary cemented total knee in approximately 22 subjects. The sequential design requires all ATTUNE TKA with reusable instruments be completed before doing any ATTUNE TKA with single use instruments.
The mechanical axis alignment will be assessed at the 3 month follow-up by independent radiographic review.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TKA with RUI
44 Subjects will receive TKA with RUI per their study doctor's standard of care. These 44 subjects will receive the TKA using Reusable instruments (RUI).
ATTUNE TKA with ATTUNE RUI
ATTUNE TKA with ATTUNE RUI
TKA with SUI
44 Subjects will receive TKA with SUI per their study doctor's standard of care. These 44 subjects will receive the TKA using Single Use Instruments (SUI).
ATTUNE TKA with ATTUNE SUI
ATTUNE TKA with ATTUNE SUI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ATTUNE TKA with ATTUNE RUI
ATTUNE TKA with ATTUNE RUI
ATTUNE TKA with ATTUNE SUI
ATTUNE TKA with ATTUNE SUI
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject is male or female and between the ages of 22 and 80 years old, inclusive.
3. Subject requires a primary total knee replacement and is considered by the Investigator to be suitable for the specific knee prosthesis identified in the protocol.
4. Subject, who, in the opinion of the Investigator, is suitable for implantation using either RUI or SUI instrumentation.
5. Subject is able to speak and read English to facilitate comprehension of the Informed Consent Document.
6. Subject has given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to DePuy Synthes Joint Reconstruction.
7. Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures.
Exclusion Criteria
2. The Subject has, in the opinion of the Investigator, an existing condition that would compromise their participation and follow-up in this study.
3. The Subject has, in the opinion of the Investigator, a flexion deformity that will not allow for 0° extension postoperatively.
4. The Subject is a woman who is pregnant or lactating.
5. The Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect follow-up care or treatment outcomes.
6. The Subject has participated in a clinical investigation with an investigational product in the last 3 months.
7. The Subject is currently involved in any personal injury litigation, medical-legal or worker's compensations claims.
8. The Subject has previous prosthetic knee replacement (any type including unicompartmental, total knee arthroplasty, patellofemoral arthroplasty or ipsilateral UTO/HTO) of the affected knee or a previous patellectomy.
9. The Subject presents with ankylosis of the hip joint on the side to be treated.
10. The Subject had a contralateral TKA and that knee was previously entered into the study.
11. The Subject requires simultaneous bilateral total knee replacements.
12. Any case in which Computer-Assisted Surgery (CAS) or TruMatch (or any other type of Custom Patient Instruments) is to be used, or any additional instrumentation are to be used for bone resections that are not provided as part of the ATTUNE RUI or SUI Instrument kits.
13. The Subject requires a device not specified in the protocol or the surgeon determines that the ATTUNE Knee System is not a suitable treatment.
22 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DePuy Orthopaedics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Verdonna Huey, MS,BSN,CCRP
Role: STUDY_DIRECTOR
DePuy Synthes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scripps Clinic Torrey Pines
La Jolla, California, United States
Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, United States
Spire Liverpool Hospital
Liverpool, , United Kingdom
Clifton Park Hospital
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.